Aurora Cannabis (ACB) Return on Assets (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Return on Assets of 0.0% for Q1 2026, up 24.0% year-on-year from 0.0% in Q1 2025, and down 663.88% on a QoQ basis from 0.0% in Q4 2025.
Aurora Cannabis (ACB) Return on Assets (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Return on Assets for 9 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.
- Quarterly Return on Assets rose 24.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (up 24.0% YoY) and the FY2026 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Assets fell to 0.0% in Q1 2026 per ACB's latest filing, from 0.0% in the prior quarter.
- Over the last five years, Return on Assets for ACB reached as high as 0.0% in Q3 2025 and fell as low as 0.24% in Q2 2025.
- A 5-year average of 0.1% and a median of 0.04% in 2024 frame the typical range for Return on Assets.
- The largest YoY upside for Return on Assets was 24 bps in 2025 against a maximum downside of 21 bps in 2025.
- Year by year, Return on Assets stood at 0.01% in 2022, then sank by 1671 bps to 0.18% in 2023, then tumbled by 34 bps to 0.24% in 2024, then surged by 100 bps to 0.0% in 2025, then slumped by 664 bps to 0.0% in 2026.
- According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.00% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.00% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.00% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.00% |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | -0.24% |
| Mar 31, 2025 | -0.24% |
| Dec 31, 2024 | -0.24% |
| Sep 30, 2024 | -0.24% |
| Jun 30, 2024 | -0.04% |
| Mar 31, 2024 | -0.18% |
| Dec 31, 2023 | -0.18% |
| Sep 30, 2023 | -0.17% |
| Jun 30, 2023 | -0.13% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |